{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:29:31Z","timestamp":1788913771560,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.drudis.2023.103487","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T11:41:09Z","timestamp":1673264469000},"page":"103487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies"],"prefix":"10.1016","volume":"28","author":[{"given":"Kendall B.E.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Jung","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2023.103487_b0005","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awx005","article-title":"A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction","volume":"140","author":"Lopez","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2023.103487_b0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.110.003293","article-title":"Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery","volume":"63","author":"Pandey","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drudis.2023.103487_b0015","article-title":"Drosophila models of tauopathies: what have we learned?","volume":"2012","author":"Gistelinck","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2023.103487_b0020","unstructured":"WHO (2017) Global Action Plan on the Public Health Response to Dementia 2017\u20132025. WHO, Geneva."},{"key":"10.1016\/j.drudis.2023.103487_b0025","unstructured":"NIA. Alzheimer's Disease Fact Sheet. www.nia.nih.gov\/health\/alzheimers-disease-fact-sheet [accessed 3 January 2023]."},{"key":"10.1016\/j.drudis.2023.103487_b0030","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2023.103487_b0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.drudis.2023.103487_b0040","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.drudis.2023.103487_b0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.drudis.2023.103487_b0050","article-title":"Short-term treatment with dabigatran alters protein expression patterns in a late-stage tau-based Alzheimer's disease mouse model","volume":"24","author":"Iannucci","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.drudis.2023.103487_b0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-2011-110161","article-title":"Tau transgenic mice as models for cerebrospinal fluid tau biomarkers","volume":"24","author":"Barten","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2023.103487_b0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0024-3205(92)90433-P","article-title":"Microtubule functions","volume":"50","author":"Avila","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.drudis.2023.103487_b0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/B978-0-444-64074-1.00047-1","article-title":"Thermoregulatory disorders in Huntington disease","volume":"157","author":"Weydt","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.drudis.2023.103487_b0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5483\/BMBRep.2018.51.6.077","article-title":"Degradation or aggregation: the ramifications of post-translational modifications on tau","volume":"51","author":"Park","year":"2018","journal-title":"BMB Rep."},{"key":"10.1016\/j.drudis.2023.103487_b0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2023.103487_b0080","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1471-4159.1998.70041346.x","article-title":"Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau","volume":"70","author":"Wei","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2023.103487_b0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2017.05.003","article-title":"Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy","volume":"105","author":"Sealey","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2023.103487_b0090","first-page":"91","article-title":"Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases","volume":"1739","author":"Andreadis","year":"2005","journal-title":"BBA"},{"key":"10.1016\/j.drudis.2023.103487_b0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-150704","article-title":"Direct evidence of internalization of tau by microglia in vitro and in vivo","volume":"50","author":"Bol\u00f3s","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2023.103487_b0100","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","article-title":"Tau PTM profiles identify patient heterogeneity and stages of Alzheimer's disease","volume":"183","author":"Wesseling","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2023.103487_b0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2023.103487_b0110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.drudis.2023.103487_b0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0896-6273(92)90117-V","article-title":"Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms","volume":"8","author":"Goedert","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2023.103487_b0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12035-018-1102-0","article-title":"First-in-rat study of human Alzheimer's disease tau propagation","volume":"56","author":"Smolek","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.drudis.2023.103487_b0125","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1021\/bi800783d","article-title":"The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments","volume":"47","author":"Jeganathan","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2023.103487_b0130","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/acschemneuro.8b00457","article-title":"Pathological changes of tau related to Alzheimer's disease","volume":"10","author":"Chu","year":"2019","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.drudis.2023.103487_b0135","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2018.00338","article-title":"Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability","volume":"12","author":"Alonso","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.drudis.2023.103487_b0140","article-title":"Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation","volume":"11","author":"Alquezar","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.drudis.2023.103487_b0145","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1016\/j.cell.2021.11.029","article-title":"Posttranslational modifications mediate the structural diversity of tauopathy strains","volume":"184","author":"Arakhamia","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2023.103487_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101442","article-title":"Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation","volume":"298","author":"Acosta","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2023.103487_b0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s40478-019-0823-2","article-title":"A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain","volume":"7","author":"Ercan-Herbst","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.drudis.2023.103487_b0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","article-title":"A current view on tau protein phosphorylation in Alzheimer's disease","volume":"69","author":"Wegmann","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.drudis.2023.103487_b0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1586\/14737175.2015.1000864","article-title":"Further understanding of tau phosphorylation: implications for therapy","volume":"15","author":"Medina","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.drudis.2023.103487_b0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drudis.2023.103487_b0175","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drudis.2023.103487_b0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.csbj.2014.09.011","article-title":"Cell-based models to investigate tau aggregation","volume":"12","author":"Lim","year":"2014","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.drudis.2023.103487_b0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1750-3639.2007.00053.x","article-title":"Structural principles of tau and the paired helical filaments of Alzheimer\u2019s disease","volume":"17","author":"Mandelkow","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.drudis.2023.103487_b0190","doi-asserted-by":"crossref","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","article-title":"Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease","volume":"268","author":"K\u00f6pke","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2023.103487_b0195","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drudis.2023.103487_b0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/BST20120134","article-title":"Tau oligomers and tau toxicity in neurodegenerative disease","volume":"40","author":"Ward","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.drudis.2023.103487_b0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmed.2005.02.008","article-title":"Tau phosphorylation in Alzheimer's disease: pathogen or protector?","volume":"11","author":"Lee","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.drudis.2023.103487_b0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnagi.2017.00083","article-title":"Tau oligomers: cytotoxicity, propagation, and mitochondrial damage","volume":"9","author":"Shafiei","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.drudis.2023.103487_b0215","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2023.103487_b0220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021461118","article-title":"Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates","volume":"118","author":"Gyparaki","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.drudis.2023.103487_b0225","doi-asserted-by":"crossref","first-page":"19011","DOI":"10.1038\/s41598-019-55419-w","article-title":"Toxic tau oligomers modulated by novel curcumin derivatives","volume":"9","author":"Lo Cascio","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2023.103487_b0230","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/pro.3499","article-title":"Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior","volume":"27","author":"Ghag","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.drudis.2023.103487_b0235","doi-asserted-by":"crossref","first-page":"17191","DOI":"10.1038\/srep17191","article-title":"Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers","volume":"5","author":"Cowan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2023.103487_b0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fneur.2013.00102","article-title":"Characteristics of tau oligomers","volume":"4","author":"Ren","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.drudis.2023.103487_b0245","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drudis.2023.103487_b0250","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnins.2018.00267","article-title":"Synaptic tau seeding precedes tau pathology in human Alzheimer's disease brain","volume":"12","author":"DeVos","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.drudis.2023.103487_b0255","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00018-007-7220-x","article-title":"Tauopathies","volume":"64","author":"Hernandez","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.drudis.2023.103487_b0260","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/brain\/awv050","article-title":"Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum","volume":"138","author":"Murray","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2023.103487_b0265","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2023.103487_b0270","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","article-title":"Alzheimer's disease drug development pipeline: 2017","volume":"3","author":"Cummings","year":"2017","journal-title":"Alzheimers Dement. (N Y)"},{"key":"10.1016\/j.drudis.2023.103487_b0275","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.drudis.2023.103487_b0280","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010\u20132015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.drudis.2023.103487_b0285","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2023.103487_b0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.drudis.2023.103487_b0295","first-page":"28","article-title":"Tau oligomers neurotoxicity","volume":"11","author":"Niewiadomska","year":"2021","journal-title":"Life (Basel)."},{"key":"10.1016\/j.drudis.2023.103487_b0300","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jnen\/nlx120","article-title":"Tau oligomer pathology in nucleus basalis neurons during the progression of Alzheimer disease","volume":"77","author":"Tiernan","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.drudis.2023.103487_b0305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.drudis.2023.103487_b0310","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2023.103487_b0315","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2014moving from amyloid-\u03b2 to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.drudis.2023.103487_b0320","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-010-0719-5","article-title":"Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis","volume":"120","author":"Boche","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.drudis.2023.103487_b0325","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/jnen\/60.10.946","article-title":"Clinical validity of A\u00df-protein deposition staging in brain aging and Alzheimer disease","volume":"60","author":"Gold","year":"2001","journal-title":"J. Neuropathol. Exper. Neurol."},{"key":"10.1016\/j.drudis.2023.103487_b0330","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.3390\/ijms22168465","article-title":"Non-rodent genetic animal models for studying tauopathy: review of Drosophila, zebrafish, and C. elegans models","volume":"22","author":"Giong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drudis.2023.103487_b0335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nan.12200","article-title":"Invited review: animal models of tauopathies and their implications for research\/translation into the clinic","volume":"41","author":"Dujardin","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.drudis.2023.103487_b0340","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/s41467-021-23597-9","article-title":"UBE4B, a microRNA-9 target gene, promotes autophagy\u2013mediated tau degradation","volume":"12","author":"Subramanian","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2023.103487_b0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd1606","article-title":"In vivo drug discovery in the zebrafish","volume":"4","author":"Zon","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2023.103487_b0350","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1172\/JCI37537","article-title":"A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation","volume":"119","author":"Paquet","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2023.103487_b0355","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0012-1606(79)90069-1","article-title":"Fertilization and sperm competition in the nematode Caenorhabditis elegans","volume":"73","author":"Ward","year":"1979","journal-title":"Dev. Biol."},{"key":"10.1016\/j.drudis.2023.103487_b0360","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1534\/genetics.118.301307","article-title":"OrthoList 2: a new comparative genomic analysis of human and Caenorhabditis elegans genes","volume":"210","author":"Kim","year":"2018","journal-title":"Genetics"},{"key":"10.1016\/j.drudis.2023.103487_b0365","first-page":"833","article-title":"Generation of stable transgenic C. elegans using microinjection","volume":"18","author":"Berkowitz","year":"2008","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.drudis.2023.103487_b0370","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2007.05.011","article-title":"A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau","volume":"30","author":"Brandt","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.drudis.2023.103487_b0375","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1073\/pnas.1533448100","article-title":"Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy","volume":"100","author":"Kraemer","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.drudis.2023.103487_b0380","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-12-407757-7.00009-8","article-title":"Analysis of microtubules in isolated axoplasm from the squid giant axon","volume":"115","author":"Song","year":"2013","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.drudis.2023.103487_b0385","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnsyn.2011.00003","article-title":"Blocking effects of human tau on squid giant synapse transmission and its prevention by T-817 MA","volume":"3","author":"Moreno","year":"2011","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.drudis.2023.103487_b0390","doi-asserted-by":"crossref","first-page":"10300","DOI":"10.1021\/bi2009147","article-title":"Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport","volume":"50","author":"Patterson","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2023.103487_b0395","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1471-4159.2009.05869.x","article-title":"Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies","volume":"108","author":"Hanes","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2023.103487_b0400","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2023.103487_b0405","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of tau pathology in a model of early Alzheimer's disease","volume":"73","author":"de Calignon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2023.103487_b0410","doi-asserted-by":"crossref","first-page":"e20190783","DOI":"10.1084\/jem.20190783","article-title":"Human tau pathology transmits glial tau aggregates in the absence of neuronal tau","volume":"217","author":"Narasimhan","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2023.103487_b0415","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41467-019-13787-x","article-title":"Transmission of tauopathy strains is independent of their isoform composition","volume":"11","author":"He","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2023.103487_b0420","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2023.103487_b0425","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.3457","article-title":"Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases","volume":"20","author":"Guo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2023.103487_b0430","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Buee","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.drudis.2023.103487_b0435","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1074\/jbc.M808759200","article-title":"Propagation of tau misfolding from the outside to the inside of a cell","volume":"284","author":"Frost","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2023.103487_b0440","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2023.103487_b0445","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.15252\/embj.201592748","article-title":"Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity","volume":"34","author":"Wegmann","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.drudis.2023.103487_b0450","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cne.21867","article-title":"Tau isoform regulation is region- and cell-specific in mouse brain","volume":"511","author":"McMillan","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.drudis.2023.103487_b0455","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2023.103487_b0460","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.neurobiolaging.2013.12.023","article-title":"Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia","volume":"35","author":"Cook","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.drudis.2023.103487_b0465","doi-asserted-by":"crossref","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","article-title":"Trans-synaptic spread of tau pathology in vivo","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2023.103487_b0470","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.drudis.2023.103487_b0475","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neuron.2020.06.010","article-title":"Selective neuronal vulnerability in Alzheimer's disease: a network-based analysis","volume":"107","author":"Roussarie","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2023.103487_b0480","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2023.103487_b0485","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.drudis.2023.103487_b0490","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/acn3.382","article-title":"Tau oligomers in cerebrospinal fluid in Alzheimer's disease","volume":"4","author":"Sengupta","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.drudis.2023.103487_b0495","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4939-6598-4_9","article-title":"Tau oligomers as pathogenic seeds: preparation and propagation in vitro and in vivo","volume":"1523","author":"Gerson","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.drudis.2023.103487_b0500","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1021\/acs.biochem.5b00309","article-title":"A comparison of three fluorophores for the detection of amyloid fibers and prefibrillar oligomeric assemblies. ThT (Thioflavin T); ANS (1-Anilinonaphthalene-8-sulfonic Acid); and bisANS (4,4 '-Dianilino-1,1 '-binaphthyl-5,5 '-disulfonic Acid)","volume":"54","author":"Younan","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2023.103487_b0505","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0076-6879(06)13012-8","article-title":"Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins","volume":"413","author":"Bitan","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.drudis.2023.103487_b0510","first-page":"1071","article-title":"Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides","volume":"23","author":"Rahimi","year":"2009","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.drudis.2023.103487_b0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2017.1304905","article-title":"ThT 101: a primer on the use of thioflavin T to investigate amyloid formation","volume":"24","author":"Gade Malmos","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.drudis.2023.103487_b0520","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1567205053585864","article-title":"Development of novel amyloid imaging agents based upon thioflavin S","volume":"2","author":"Wei","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.drudis.2023.103487_b0525","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jalz.2009.06.002","article-title":"Characterization of tau fibrillization in vitro","volume":"6","author":"Xu","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.drudis.2023.103487_b0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2010.09.018","article-title":"Amyloid structure and assembly: insights from scanning transmission electron microscopy","volume":"173","author":"Goldsbury","year":"2011","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.drudis.2023.103487_b0535","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2023.103487_b0540","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.590896","article-title":"New insights into drug discovery targeting tau protein","volume":"13","author":"Soeda","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.drudis.2023.103487_b0545","doi-asserted-by":"crossref","first-page":"16551","DOI":"10.1038\/s41598-020-73680-2","article-title":"Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2023.103487_b0550","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.drudis.2023.103487_b0555","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1046\/j.1471-4159.1996.67031183.x","article-title":"Polymerization of \u03c4 into filaments in the presence of heparin: the minimal sequence required for \u03c4 - \u03c4 interaction","volume":"67","author":"P\u00e9rez","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2023.103487_b0560","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3233\/JAD-181001","article-title":"Methylene blue inhibits formation of tau fibrils but not of granular tau oligomers: a plausible key to understanding failure of a clinical trial for Alzheimer's disease","volume":"68","author":"Soeda","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2023.103487_b0565","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/alz.12453","article-title":"A critical appraisal of tau-targeting therapies for primary and secondary tauopathies","volume":"18","author":"Imbimbo","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.drudis.2023.103487_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133574","article-title":"Anti-fibrillization effects of sulfonamide derivatives on alpha\u2013synuclein and hyperphosphorylated tau isoform 1N4R","volume":"1267","author":"Fortin","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.drudis.2023.103487_b0575","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-021-01147-0","article-title":"Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice","volume":"9","author":"Bajracharya","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.drudis.2023.103487_b0580","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3233\/JAD-191266","article-title":"A single-chain variable fragment antibody inhibits aggregation of phosphorylated tau and ameliorates tau toxicity in vitro and in vivo","volume":"79","author":"Li","year":"2021","journal-title":"J. Alzheimers Dis."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462300003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462300003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:04:37Z","timestamp":1761224677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964462300003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":116,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S135964462300003X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103487","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103487"}}